The Healthcare Association of Hawaii has conferred its 2024 Achievement in Advocacy Award on House Speaker Scott Saiki.

Speaker Saiki has been a steady champion for ensuring that all Hawai`i residents have access to critical services, including preventive care. He was a leader in bringing together public and private resources to stand up COVID-19 vaccination sites throughout the state, ensuring that vulnerable residents could be protected as soon as possible. The speaker has also supported innovative programs to grow our healthcare workforce. In the years between 2019 and 2022, the number of vacant patient-facing, non-physician jobs nearly doubled.

Click here to read the full release.

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Session 9 – June 7, 2024: Management of Patients on MOUD: Key Takeaways and Series Wrap-up

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 7 (Part 1: Presentation) and 8 (Part 2: Panel Discussion) – April 12, 2024 and May 10, 2024: Sustaining Recovery for Patients on MOUD Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 7 (Part 1: Presentation) and 8 (Part 2: Panel Discussion) – April 12, 2024 and May 10, 2024: Sustaining Recovery for Patients on MOUD Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 5 (Part 1: Presentation) and 6 (Part 2: Panel Discussion) – February 9, 2024 and March 8, 2024: Management of Patients on MOUD During the Nursing Home Stay Admissions assessment and treatment, addressing stigma and naloxone training

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 5 (Part 1: Presentation) and 6 (Part 2: Panel Discussion) – February 9, 2024 and March 8, 2024: Management of Patients on MOUD During the Nursing Home Stay Admissions assessment and treatment, addressing stigma and naloxone training

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 3 (Part 1: Presentation) and 4 (Part 2: Panel Discussion) – November 17, 2023 and January 12, 2024: Seamlessly Transitioning Patients on MOUD to Nursing Homes Discharge planning, medication reconciliation and readmission prevention

This webinar series is designed to empower nursing home professionals with the knowledge and strategies needed to navigate the top risk areas associated with Immediate Jeopardy (IJ) citations. Drawing from real life examples of IJ citations, we’ll delve into actionable solutions to prevent these critical citations in facilities.

Click here for more information.

Nov. 30 and Dec. 1, 2023
8 am - 4:30 pm
Ala Moana Hotel
Register here

The Joint Commission (TJC) accredits and certifies nearly 21,000 healthcare organizations and programs in the United States. Joint Commission accreditation and certification is recognized nationwide as a symbol of quality that reflects an organization’s commitment to meeting certain performance standards.

The mission of Joint Commission Resources is to continuously improve the safety and quality of healthcare in the United States and in the international community through the provision of education, publications, consultation, and evaluation services. Their services assist in preparing accredited providers for survey.

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Sessions 3 (Part 1: Presentation) and 4 (Part 2: Panel Discussion) – November 17, 2023 and January 12, 2024: Seamlessly Transitioning Patients on MOUD to Nursing Homes Discharge planning, medication reconciliation and readmission prevention

Nov. 15 at 12 pm HST
Click here to register

It seems like every day we read about new cyber threats. No organization is immune. Despite their best efforts, even well-known organizations such as the University of Hawai‘i, Hawai‘i Department of Health and Aloha Nursing Rehab Center have become victims. Cyber threats can impact businesses of any size and the threat actors have become extremely sophisticated. It is no longer a question of if you'll be impacted, but when. As a small business, you can mount a robust cyber defense to protect your company and the sensitive information of your customers from ransomware and other emerging threats. In this webinar, you'll learn about:

- Who regulates cyber security
- Why it's important to comply
- How to manage risk by prioritizing your investment in security controls
- Why it's critical to involve human resources in cybersecurity
- When cyber insurance may be appropriate
- What your next steps should be

The Hawai'i Department of Health Harm Reduction Services Branch are excited to invite you to the 2023 Hawai'i STI Clinical Update in partnership with California Prevention Training Center (CAPTC), a one-day in-person training event designed exclusively for healthcare providers in Hawai'i. This event is scheduled for October 17th, 2023, from 9 am to 5 pm HST at the DoubleTree Waikiki Beach.

In-person capacity is limited to 80 participants. If livestreaming becomes available, separate registration link to follow.

Topics include syphilis in pregnancy, congenital syphilis, DoxyPEP, and more.

If you have any questions, please contact Elizabeth Olson (elizabeth.olson@ucsf.edu) or the DOH Harm Reduction Service Branch’s STI Prevention Program (doh.spp@doh.hawaii.gov).

Registration

SATURDAY, OCTOBER 14, 2023

10AM-3:30PM HST

Hawaii Convention Ctr. - Meeting Room #313A

Updates in Neurological Medicine

This one-day CME/CE accredited conference will update allied health care professionals on current topics in neurology from nationally recognized speakers.

Each session will present current, evidence-based data relating to the diagnosis and management of commonly encountered neurological disorders and will give providers an opportunity to share knowledge and experiences with the purpose of enhancing patient care.

Click here to register.

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Session 2 – October 13, 2023: Role of the Pharmacist in the Treatment of Patients with OUD Medication processes, addressing opioid adverse drug events (ADEs) and risk assessment for opioid prescribing

Wednesday, September 20, 2023, 10-11:30am Hawaii time

James H. Pietsch, JD is the speaker.

• It is wise for adults to have a plan in place in the event of death or incapacity, especially for those who may

be starting to experience memory loss or a decline in thinking skills as can be seen in dementia.

• Planning for death and incapacity, especially for those diagnosed with dementia, usually involves the

consideration of such essential legal and related documents such as wills, durable powers of attorney for

legal and financial matters, advance health care directives, including durable powers of attorney for

health care and individual instructions for health care, plus for many, provider orders for life-sustaining

treatment and living trusts.

• A diagnosis of dementia does not necessarily indicate a current lack of capacity to execute essential

documents legal and related documents, so it is important to seek professional legal and health care

advice early on.

• The levels of capacity necessary to understand and to execute various legal documents vary and it is

important to seek the assistance of a qualified attorney to provide counsel, advice, and assistance.

• Legal Documents and related forms are often complicated so it may be beneficial to look over some

samples commonly used in Hawaii found in the handbook highlighted in this presentation.

Advance Registration is required at this link:

https://www.eventbrite.com/e/essential-legal-planning-issues-for-dementia-tickets-

706567150367?aff=oddtdtcreator

The Zoom link & handouts will be sent separately via email to registrants before the session date.

Sorry, no CEs or certificates are available for this presentation

For questions about the workshops contact: Jody Mishan, (808) 295-2624 or jmishan@hawaii.rr.com

More than one million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.1

However, fewer than one in five Medicare beneficiaries with an OUD diagnosis received medication to treat this condition. Also, the number of patients who stay in treatment after hospital discharge decreases drastically during the transition of care.2

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.

Please join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.

Sessions will take place on Fridays at 12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT.

Register for this no-cost series: https://bit.ly/MOUDthroughCareContinuumSeries

Session 1 – September 15, 2023: Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD Basics and science of addiction and screening and initiating MOUD

Thursday, Sept. 7 at 8 am Hawaii Time.

Join Alzheimer's Association Chief Science Officer, Maria C. Carrillo, Ph.D., who will present cutting-edge science from this year's Alzheimer’s Association International Conference® (AAIC®) and share insights on the most pressing healthcare issue of our time.

Click here to register.

HAH is partnering with Good Jobs Hawai`i, a coalition of educators, businesses, and other community partners that will help people in Hawai‘i get high quality jobs and careers, while ensuring employers meet their needs for a skilled, local workforce. Click here for more information.

The Hawaii Department of Commerce and Consumer Affairs has a new emergency rule which extends the licensure waiver and allows LPNs, RNs, and APRNs, who have a current and unencumbered license in another state, territory, or country, to temporarily practice in Hawaii.

The emergency rule is effective for 120 days (eff. 12/5/2022 – 4/4/2023). Each nurse’s authorization to temporarily practice is valid for 90 days after the date of confirmation by the DCCA.  

In order to receive an emergency temporary permit for out-of-state licensed nursing staff, healthcare entities must submit a list of those seeking temporary practice under the waiver to the DCCA. Please see the following link for the required form and the address of the Board of Nursing (at the end of the form) to submit once complete: https://cca.hawaii.gov/pvl/files/2022/08/ER-form-for-list-of-nurses_fillable.pdf

Full language of the emergency rule can be found here: 2022-Nurses-Emergenc-Rules_12.05.22.pdf (hawaii.gov)

These webinars will take a deep dive into key long-term care (LTC) federal regulations with an emphasis on reviewing the most commonly cited areas for each requirement. Actual citation examples will be discussed, as well as strategies for successfully managing the survey process. Click here for more information.